Anticoagulant Overdose With Paradoxical Thrombotic Risk

Area of Science:

• Cardiology
• Clinical Toxicology
• Pharmacology

Background:

• Patients with metallic heart valves require anticoagulation therapy, typically with warfarin, to prevent thromboembolic events.
• Discontinuation of anticoagulation therapy can lead to a prothrombotic state, increasing the risk of clot formation.
• Polypharmacy overdose presents unique challenges in patient management due to complex drug interactions and varied toxic effects.

Observation:

• A patient with a metallic heart valve presented with a polypharmacy overdose, including warfarin.
• The patient had recently discontinued his prescribed anticoagulation therapy for several months prior to presentation.
• This cessation of anticoagulation placed the patient in an initial prothrombotic phase.

Findings:

• The combination of polypharmacy overdose and a prothrombotic state due to prior anticoagulation cessation creates a complex clinical scenario.
• Accurate and rapid elucidation of all patient-specific clinical details is paramount for effective management.
• Warfarin management in overdose requires careful consideration of the patient's underlying thrombotic risk.

Implications:

• This case underscores the critical need for thorough patient history taking in overdose cases, especially concerning medication adherence.
• Clinicians must be vigilant in assessing thrombotic risk in patients with metallic heart valves who present with overdose and a history of anticoagulation non-adherence.
• Prompt and accurate diagnosis of the contributing factors is essential for guiding appropriate and potentially life-saving interventions in complex overdose scenarios.